Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: Systematic review with meta-analysis combining individual patient and aggregate data
Ulrich Ronellenfitsch(University of Mannheim), Katrin Jensen(Heidelberg University), Bryan Burmeister(Princess Alexandra Hospital), Marc Ychou(Inserm), Christoph Schuhmacher(Heidelberg University), Cornelis J.�H. van de Velde(Leiden University Medical Center), Ralf‐Dieter Hofheinz(Goethe University Frankfurt), Meinhard Kieser(Heidelberg University), David P. Kelsen(Memorial Sloan Kettering Cancer Center), Donna Niedzwiecki(Duke University), Matthias Schwarzbach(Klinikum Frankfurt Höchst), Susan G. Urba(University of Michigan), Tracy Slanger(Institute for Quality and Efficiency in Health Care), Peter Kienle(Heidelberg University), T. N. Walsh(Connolly Hospital Blanchardstown)
Cited by 169
Related Papers
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.8k
Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
|Journal of Clinical Oncology|2011|2.1k
Vemurafenib in Multiple Nonmelanoma Cancers with <i>BRAF</i> V600 Mutations
|New England Journal of Medicine|2015|1.7k
Definition and grading of anastomotic leakage following anterior resection of the rectum: A proposal by the International Study Group of Rectal Cancer
|Surgery|2009|1.5k
Genome-wide cell-free DNA fragmentation in patients with cancer
|Nature|2019|1.5k